tiprankstipranks
Trending News
More News >
ASEP Medical Holdings Inc (TSE:ASEP)
:ASEP
Canadian Market

ASEP Medical Holdings Inc (ASEP) Ratios

Compare
7 Followers

ASEP Medical Holdings Inc Ratios

TSE:ASEP's free cash flow for Q3 2024 was C$0.55. For the 2024 fiscal year, TSE:ASEP's free cash flow was decreased by C$ and operating cash flow was C$-12.87. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.04 0.25 6.43 39.90 0.07
Quick Ratio
0.04 0.25 6.43 39.90 0.07
Cash Ratio
<0.01 0.07 4.03 36.68 0.05
Solvency Ratio
-0.27 -2.27 -8.47 -14.74 0.00
Operating Cash Flow Ratio
-0.08 -2.72 -6.84 -8.26 -0.14
Short-Term Operating Cash Flow Coverage
-8.22 -135.63 0.00 0.00 -0.16
Net Current Asset Value
C$ -4.32MC$ -2.80MC$ 2.87MC$ 5.61MC$ -150.53K
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.00 0.00 12.82
Debt-to-Equity Ratio
<0.01 <0.01 0.00 0.00 -0.93
Debt-to-Capital Ratio
<0.01 <0.01 0.00 0.00 -14.34
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.30 2.03 1.75 1.68 -0.07
Debt Service Coverage Ratio
-69.56 -401.38 -5.50K -19.83 0.00
Interest Coverage Ratio
-1.72K -28.60K -6.69K -19.39 0.00
Debt to Market Cap
<0.01 <0.01 0.00 0.00 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
>-0.01 <0.01 0.47 2.56 0.00
Profitability Margins
Gross Profit Margin
50.86%-538.03%0.00%0.00%0.00%
EBIT Margin
-1534.81%-44608.55%0.00%0.00%0.00%
EBITDA Margin
-1096.30%-38486.19%0.00%0.00%0.00%
Operating Profit Margin
-1481.23%-36524.42%0.00%0.00%0.00%
Pretax Profit Margin
-1544.61%-44609.81%0.00%0.00%0.00%
Net Profit Margin
-1247.13%-38918.30%0.00%0.00%0.00%
Continuous Operations Profit Margin
-1544.61%-44609.81%0.00%0.00%0.00%
Net Income Per EBT
80.74%87.24%98.48%98.23%100.00%
EBT Per EBIT
104.28%122.14%107.42%118.50%100.00%
Return on Assets (ROA)
-7.64%-32.12%-21.26%-7.49%-255.89%
Return on Equity (ROE)
-17.04%-65.23%-37.22%-12.61%18.67%
Return on Capital Employed (ROCE)
-10.05%-31.37%-20.50%-6.47%18.67%
Return on Invested Capital (ROIC)
-10.04%-31.34%-20.19%-6.35%286.24%
Return on Tangible Assets
-80.00%-308.93%-166.93%-39.57%-255.89%
Earnings Yield
-4.85%-64.49%-16.01%-8.20%-0.19%
Efficiency Ratios
Receivables Turnover
3.08 0.83 0.00 0.00 0.00
Payables Turnover
0.07 0.31 0.32 1.23 1.27
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.52 0.57 0.00 0.00 0.00
Asset Turnover
<0.01 <0.01 0.00 0.00 0.00
Working Capital Turnover Ratio
-0.07 0.02 0.00 0.00 0.00
Cash Conversion Cycle
-4.88K -720.43 -1.12K -297.07 -286.97
Days of Sales Outstanding
118.39 438.95 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
5.00K 1.16K 1.12K 297.07 286.97
Operating Cycle
118.39 438.95 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.04 -0.06 -0.02 >-0.01
Free Cash Flow Per Share
>-0.01 -0.04 -0.06 -0.02 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.10 1.00
Dividend Paid and CapEx Coverage Ratio
-959.21 -606.71 -8.31K -10.29 0.00
Capital Expenditure Coverage Ratio
-959.21 -606.71 -8.31K -10.29 0.00
Operating Cash Flow Coverage Ratio
-8.22 -135.63 0.00 0.00 -0.16
Operating Cash Flow to Sales Ratio
-1.22 -128.32 0.00 0.00 0.00
Free Cash Flow Yield
-3.28%-21.30%-10.05%-4.66%-0.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-20.60 -1.55 -6.25 -12.19 -530.50
Price-to-Sales (P/S) Ratio
37.38 603.52 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
3.62 1.01 2.32 1.54 -99.02
Price-to-Free Cash Flow (P/FCF) Ratio
-30.49 -4.70 -9.95 -21.48 -673.79
Price-to-Operating Cash Flow Ratio
-209.72 -4.70 -9.95 -23.56 -673.79
Price-to-Earnings Growth (PEG) Ratio
-1.40 -0.05 -0.04 >-0.01 0.00
Price-to-Fair Value
3.62 1.01 2.32 1.54 -99.02
Enterprise Value Multiple
-3.42 -1.56 -7.41 -11.03 0.00
Enterprise Value
5.57M 12.71M 33.84M 22.78M 15.04M
EV to EBITDA
-3.42 -1.56 -7.41 -11.03 0.00
EV to Sales
37.45 601.40 0.00 0.00 0.00
EV to Free Cash Flow
-30.54 -4.68 -9.36 -17.43 -679.77
EV to Operating Cash Flow
-30.57 -4.69 -9.36 -19.12 -679.77
Tangible Book Value Per Share
-0.03 >-0.01 0.05 0.10 -0.01
Shareholders’ Equity Per Share
0.14 0.20 0.28 0.33 -0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.02 0.02 0.00
Revenue Per Share
<0.01 <0.01 0.00 0.00 0.00
Net Income Per Share
-0.02 -0.13 -0.10 -0.04 >-0.01
Tax Burden
0.81 0.87 0.98 0.98 1.00
Interest Burden
1.01 1.00 1.00 1.05 1.00
Research & Development to Revenue
0.31 32.10 0.00 0.00 0.00
SG&A to Revenue
8.19 200.18 0.00 0.00 0.00
Stock-Based Compensation to Revenue
2.26 92.34 0.00 0.00 0.00
Income Quality
0.09 0.33 0.63 0.51 0.79
Currency in CAD